Lataa...
[60]Fullerene for Medicinal Purposes, A Purity Criterion towards Regulatory Considerations
Since the early nineties countless publications have reported promising medicinal applications for [60]fullerene (C<sub>60</sub>) related to its unparalleled affinity towards free radicals. Yet, until now no officially approved C<sub>60</sub>-based drug has reached the market...
Tallennettuna:
| Päätekijät: | , , , , , , |
|---|---|
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
MDPI AG
2019-08-01
|
| Sarja: | Materials |
| Aiheet: | |
| Linkit: | https://www.mdpi.com/1996-1944/12/16/2571 |
| Tagit: |
Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!
|